Combination of three miRNA (miR-141, miR-21, and miR-375) as potential diagnostic tool for prostate cancer recognition

ConclusionsOur results support previous findings on the possibility of discriminating prostate cancer patients from healthy controls by detecting miRNA (miR-141-3p, miR-21, and miR-375). Further insights into miRNA abundance and characteristics are necessary to validate the panel of miRNA as surrogate markers in diagnosis of prostate cancer.

http://link.springer.com/10.1007/s11255-018-1938-2

Source: International Urology and Nephrology - July 16, 2018 Category: Urology & Nephrology Source Type: research